Enhabit (NYSE:EHAB) EVP Julie Diane Jolley Sells 2,793 Shares

Enhabit, Inc. (NYSE:EHAB) EVP Julie Diane Jolley sold 2,793 shares of Enhabit stock in a transaction on Monday, March 9th. The shares were sold at an average price of $13.63, for a total transaction of $38,068.59. Following the completion of the transaction, the executive vice president owned 139,923 shares in the company, valued at approximately $1,907,150.49. This trade represents a 1.96% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Enhabit Trading Down 0.0%

Shares of NYSE EHAB traded down $0.01 during trading on Thursday, hitting $13.62. 821,112 shares of the company traded hands, compared to its average volume of 1,372,830. The firm has a market capitalization of $690.59 million, a P/E ratio of -151.28 and a beta of 1.56. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.76. The company has a 50-day moving average price of $11.39 and a 200-day moving average price of $9.49. Enhabit, Inc. has a 1 year low of $6.47 and a 1 year high of $13.68.

Enhabit (NYSE:EHAB) last issued its earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, hitting the consensus estimate of $0.14. Enhabit had a positive return on equity of 4.71% and a negative net margin of 0.43%.The business had revenue of $270.40 million for the quarter, compared to analyst estimates of $270.56 million. On average, equities analysts predict that Enhabit, Inc. will post 0.22 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. UBS Group reaffirmed a “neutral” rating and issued a $13.80 price objective (up from $12.00) on shares of Enhabit in a research note on Tuesday, February 24th. Jefferies Financial Group downgraded shares of Enhabit from a “buy” rating to a “hold” rating and increased their target price for the stock from $12.50 to $13.80 in a research report on Monday, February 23rd. Weiss Ratings restated a “sell (e+)” rating on shares of Enhabit in a report on Monday, December 29th. Truist Financial set a $13.80 price target on shares of Enhabit in a research report on Monday, February 23rd. Finally, Leerink Partners boosted their price objective on shares of Enhabit from $9.50 to $13.80 and gave the stock a “market perform” rating in a research note on Monday, February 23rd. Two analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $13.57.

Institutional Investors Weigh In On Enhabit

A number of large investors have recently modified their holdings of the stock. AQR Capital Management LLC lifted its position in Enhabit by 115.6% during the 1st quarter. AQR Capital Management LLC now owns 215,341 shares of the company’s stock worth $1,867,000 after acquiring an additional 115,456 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Enhabit by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,813 shares of the company’s stock valued at $262,000 after acquiring an additional 1,248 shares in the last quarter. Jones Financial Companies Lllp raised its stake in shares of Enhabit by 110,987.5% during the first quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock valued at $78,000 after purchasing an additional 8,879 shares during the period. Empowered Funds LLC raised its stake in shares of Enhabit by 8.4% during the first quarter. Empowered Funds LLC now owns 190,514 shares of the company’s stock valued at $1,675,000 after purchasing an additional 14,690 shares during the period. Finally, Acadian Asset Management LLC acquired a new position in shares of Enhabit during the first quarter worth $114,000.

About Enhabit

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.